Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Keratosis, Actinic 3Glioma 3Glioblastoma 2Carcinoma, Basal Cell 2Brain Neoplasms 2Skin Neoplasms 1Pituitary Neoplasms 1Oligodendroglioma 1Neuroectodermal Tumors 1Neoplasms, Neuroepithelial 1Neoplasms, Basal Cell 1Neoplasms 1Neoplasm, Residual 1Neoplasm Metastasis 1Central Nervous System Neoplasms 1Carcinoma, Squamous Cell 1Astrocytoma 1

Interventions

Dexmedetomidine 3Saline Solution 2Hydrocortisone 2parecoxib 1loxoprofen 1lanreotide 1Visual Field Tests 1Visual Acuity 1Transcranial Magnetic Stimulation 1Tramadol 1Temozolomide 1TBR-760 1Surgical Procedures, Operative 1Solutions 1Sodium Chloride 1Sevoflurane 1Rosiglitazone 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy 1Radiosurgery 1Propofol 1Prednisone 1Positron-Emission Tomography 1Nasal Lavage 1Magnetic Resonance Spectroscopy 1Injections 1Fluorodeoxyglucose F18 1Early Intervention, Educational 1Diffusion Tensor Imaging 1Desflurane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Pituitary Neoplasms × Aminolevulinic Acid × Clear all
NCT04390802 2021-02-24

A Pilot Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Pituitary Adenomas

Massachusetts General Hospital

Unknown
40 enrolled
Endocrine

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡